This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of bioactive molecules. It serves as a key intermediate in the creation of potential therapeutic agents, often targeting central nervous system disorders. Its structure, featuring both cyclopropyl and pyridyl groups, makes it valuable for designing compounds with specific receptor-binding properties. Researchers leverage it to develop drugs that may modulate neurotransmitter activity, offering potential treatments for conditions like depression, anxiety, or neurodegenerative diseases. Additionally, its unique chemical framework is explored in the development of enzyme inhibitors, which could be applied in treating various metabolic or infectious diseases.